601628 China Life Insurance
- 30.97
- -0.25-0.80%
China Life Insurance News
Analysts Offer Insights on Financial Companies: UBS Group AG (UBS) and China Life Insurance Co (OtherCILJF)
Nomura Adjusts China Life Insurance's Price Target to HK$14.98 From HK$14.76, Keeps at Buy
05:48 AM EDT, 05/08/2024 (MT Newswires) -- Nomura Adjusts China Life Insurance's Price Target to HK$14.98 From HK$14.76, Keeps at Buy Price (HKD): $10.92, Change: $-0.28, Percent Change: -2.50%
Nomura Adjusts New China Life's Price Target to 30.01 Yuan From 33.07 Yuan, Keeps at Neutral
05:21 AM EDT, 05/08/2024 (MT Newswires) -- Nomura Adjusts New China Life's Price Target to 30.01 Yuan From 33.07 Yuan, Keeps at Neutral Price (RMB): ¥31.61, Change: ¥-0.82, Percent Change: -2.53%
Nomura Adjusts New China Life's Price Target to HK$20.29 From HK$23.70, Keeps at Buy
05:21 AM EDT, 05/08/2024 (MT Newswires) -- Nomura Adjusts New China Life's Price Target to HK$20.29 From HK$23.70, Keeps at Buy Price (HKD): $15.52, Change: $-0.58, Percent Change: -3.60%
Nomura: The target price for China Life Insurance (02628)'s “buy” rating was raised to HK$14.98
The Zhitong Finance App learned that after adopting the new accounting standards, Nomura released a research report saying that after adopting the new accounting standards, the net profit forecast for this year and next two years was raised by 8% and 1%, the net asset forecast was raised by 1%, and the dividend payout forecast per share was also raised accordingly. It was pointed out that after implementing the new accounting standards for insurance contracts and financial instruments in the first quarter of this year, the target price was raised from HK$14.76 to HK$14.98, with a rating of “buy”.
Citibank: Maintaining China Life's (02628) “Buy” Rating Target Price Reduction to HK$15.6
Citi lowered China Life Insurance's (02628) earnings estimates per share for the 2024-2026 fiscal year by 6%, 5%, and 5%, respectively.
Changes in Hong Kong stocks | Domestic insurance stocks continued to rise, insurers NBV performed well in the first quarter, and the sector's valuation rebound is expected to continue
Domestic insurance stocks continued to rise. As of press release, Zhongan Online (06060) rose 4.33% to HK$14.46; China Taibao (02601) rose 3.89% to HK$18.7.
BOC International: Maintaining China Life's “Buy” Rating and Lowering Target Price to HK$14
BOC International released a research report stating that it maintains the “buy” rating of China Life Insurance (02628) and expects net profit to be 46.6 billion yuan under the new standards in 2024. Since the share of the company's transactional financial assets (31%) of investment assets is relatively higher than that of peers, it is expected to cause profit volatility. The target price was lowered from HK$17 to HK$14. Currently, the valuation is still attractive. According to the report, as of the end of 1Q24, the company's core solvency ratio was 154.97%, down 3 percentage points from the end of the previous year, mainly due to the increase in capital with minimum market risk due to increased equity allocation. In the past 3 years, the company has increased the allocation of long-term bonds
[Broker Focus] BOC International cuts China Life Insurance (02628) target price by 17.64% and maintains purchase rating
Jinwu Financial News | According to BOC International Development Research Report, China Life (02628) 1Q24 net profit fell 9.3% year on year. The decline in profit was mainly due to the 20.4% year-on-year decline in insurance service performance due to increased compensation payments. According to the bank, premium income increased by 3.2% year on year. The increase was mainly due to renewed premiums. The significant year-on-year decline in premium payments reduced the premium growth rate. The premium structure has been optimized, and the proportion of premiums paid over a ten-year term has increased significantly. The value of new business increased significantly, and the value rate of new business increased year-on-year. The return on investment declined year over year. The bank continued that as of the end of 1Q24, under the company's core solvency adequacy ratio
China Life Insurance (02628.HK) gains 13.726 million shares from FMR LLC
Gelonghui, April 30丨According to the latest equity disclosure data from the Stock Exchange, on April 24, 2024, China Life (02628.HK) obtained FMR LLC to increase its holdings by 13.7.26 million shares at an average price of HK$9.8712 per share on the market, involving approximately HK$135 million. After the increase in holdings, FMR LLC's latest shareholding was 523,801,919 shares, and the shareholding ratio increased from 6.85% to 7.04%.
China Life Insurance GAAP EPS of RMB 1.58, Revenue of RMB 26.5B
New China Life Insurance 1Q Net CNY4.94B, Down 29% on Year >1336.HK
New China Life Insurance 1Q Net CNY4.94B, Down 29% on Year >1336.HK
China Life Insurance: Insurer's “Head Goose” ESG Leading the Way
In this past annual reporting season, many listed companies will publish an “Environmental, Social and Governance (ESG) and Social Responsibility Report” in addition to the previous year's annual report. ESG refers to environmental (environmental), social (social), and governance (governance). In 2004, the UN Global Compat (UN Global Compat) first officially proposed the ESG concept. This year marks the 20th anniversary of the introduction of the ESG concept. Over the past 20 years, ESG has become an important measure of a company's ability to operate sustainably. With ES
China Life Insurance (02628) elected Cao Weiqing as the employee representative supervisor of the 8th Supervisory Board
China Life Insurance (02628) issued an announcement. The 12th Interim Meeting of the Company's 3rd Workers' Congress elected Cao Weiqing,...
Changes in Hong Kong stocks | Insurance stocks continue to strengthen, insurer NBV's performance exceeded expectations in the first quarter, and sector valuation repair is expected to continue under asset-side catalysts
The Zhitong Finance App learned that insurance stocks continued to strengthen in early trading. As of press release, AIA (01299) rose 9.07% to HK$58.9; China Taibao (02601) rose 5.72% to HK$18.12; China Life (02628) rose 4.85% to HK$10.8; Xinhua Insurance (01336) rose 4.61% to HK$15.44; Ping An (02318) rose 4.33% to HK$37.35. According to the news, judging from the quarterly reports of listed insurers currently disclosed, the overall year-on-year growth rate of insurers NBV has exceeded expectations under comparable standards. Among them
Goldman Sachs: A target price of HK$14 for a “buy” rating for China Life (02628)
China Life Insurance management indicated that it is also currently actively controlling the term of debt, and it is expected that the gap between assets and liabilities will continue to narrow during their lifetime.
China Life Insurance 1Q First Year Regular Premiums Rose 4.7% on Year >2628.HK
China Life Insurance 1Q First Year Regular Premiums Rose 4.7% on Year >2628.HK
China Life Insurance 1Q Net CNY20.64B Vs. Net CNY22.77B >2628.HK
China Life Insurance 1Q Net CNY20.64B Vs. Net CNY22.77B >2628.HK
China Life Insurance (02628) plans to sign a supplementary agreement with China Life Insurance Real Estate to increase the amount of capital pledged to the partnership
China Life Insurance (02628) announced that the company plans to sign a supplementary agreement with China Life Insurance by December 31, 2024...
中國人壽：2024年第一季度報告
Analysis
Price Target
No Data
